First-line drugs for hypertension - Wikidata - awgldk - TriplyDB

First-line drugs for hypertension

First-line drugs for hypertension

http://www.wikidata.org/entity/Q24239935

about

Lay perspectives on hypertension and drug adherence: systematic review of qualitative research Blood pressure lowering efficacy of beta-1 selective beta blockers for primary hypertension Antihypertensive pharmacotherapy for prevention of sudden cardiac death in hypertensive individuals Medication review in hospitalised patients to reduce morbidity and mortality First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension Organisational interventions for improving control of blood pressure in individuals with hypertension Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension Blood pressure-lowering efficacy of loop diuretics for primary hypertension Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension Beta blockers for peripheral arterial disease General health checks in adults for reducing morbidity and mortality from disease Blood pressure lowering efficacy of nonselective beta-blockers for primary hypertension First-line beta-blockers versus other antihypertensive medications for chronic type B aortic dissection Time course for blood pressure lowering of alpha blockers Time course for blood pressure lowering of beta one selective blockers Blood pressure lowering efficacy of alpha blockers for primary hypertension Garlic for the prevention of cardiovascular morbidity and mortality in hypertensive patients Time course for blood pressure lowering of angiotensin-converting-enzyme inhibitors Time course for blood pressure lowering of dual alpha and beta blockers First-line diuretics versus other classes of antihypertensive drugs for hypertension Cordyceps sinensis for hypertension in adults Thiazide diuretics and the risk of hip fracture Calcium channel blockers versus other classes of drugs for hypertension Walking for hypertension Blood pressure lowering efficacy of loop diuretics for primary hypertension Blood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertension Blood pressure lowering efficacy of diuretics as second-line therapy for primary hypertension Blood pressure lowering efficacy of clonidine for primary hypertension Dyslipidemia management in primary prevention of cardiovascular disease: Current guidelines and strategies Home blood pressure monitoring: Australian Expert Consensus Statement.Outpatient Hypertension Control and Prescribing Habits for Hypertension in Taiwan Physician perception of blood pressure control and treatment behavior in high-risk hypertensive patients: a cross-sectional study Beta-blockers for hypertension.First-line combination therapy versus first-line monotherapy for primary hypertension.Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: systematic review and multiple treatments meta-analysis.Factors affecting blood pressure variability: lessons learned from two systematic reviews of randomized controlled trials.Cardiovascular risk management and its impact on hypertension control in primary care in low-resource settings: a cluster-randomized trial.Diuretic drugs benefit patients with hypertension more with night-time dosing What differentiates primary care physicians who predominantly prescribe diuretics for treating mild to moderate hypertension from those who do not? A comparative qualitative study

P2860

Q22306534-CB0E4F73-E583-408D-983C-09031AFE3AE3 Q24186037-DE729228-B9D7-48E6-B8AB-DAAB99878DAA Q24186039-661B07E3-E096-4121-9A87-D86AFFE5C105 Q24186116-C2B9992D-E9E4-4F22-A5EE-677E19BE6FBA Q24186647-B483FAD5-E0E3-4B36-BD22-19C5E4CB159B Q24186835-8BBB5C22-FF22-4FCA-B6E6-E60FE6FFCF30 Q24187752-EE22D66F-442C-4827-A9DD-DE56DC3865C2 Q24187853-C56FAB66-90F8-482C-B7F3-CC571688C7D7 Q24194304-88D6B265-DFA2-4DEB-9C5F-90F0071A10D5 Q24194532-9650D3A5-8963-4382-8457-96A6815043A3 Q24198127-B2833996-8BB9-4475-A459-C24942D88E25 Q24198193-177D9345-7211-46F4-9CD2-80E9BCA893AF Q24200205-990E7965-5077-4F2D-8645-1BFDF1868E19 Q24200255-B50542EA-FD86-4B09-81BA-FF68DBD2E1C5 Q24201056-13E25107-A109-4616-84A1-D39496BD0CE7 Q24201091-B8050598-6695-47D2-9FA5-3A973E37ACCF Q24201322-3194A822-F5AB-447F-A634-91D0FAEAD8A3 Q24201536-330ED1BE-05E0-4887-B002-9CE677463286 Q24201753-3548E4FF-FDCB-4174-AB16-EE5170C3FFF4 Q24201866-E956AB5A-1900-4BAD-9B6C-4ECFB3DDC69F Q24234045-54BEAF02-F2AF-48B8-84FB-8064A2B6A5A8 Q24236000-5C354733-2DD4-42EE-93E7-B81D53207054 Q24236268-514092FE-0FBA-48AC-9F68-0FDC74DBE501 Q24236584-1985D3F2-06EF-48E1-8E5C-401213FE85CE Q24236765-3BBB01DF-2804-4780-BEA5-F4E40114545A Q24240420-9BCF5323-5EE5-4F15-B403-43F02EE47D83 Q24240505-460BB37F-C0C5-4D9C-A42D-994FF79398A8 Q24240561-D7D28CB7-677C-43AE-9FDD-C5EF127F50FD Q24241517-1B285A84-1B7E-4B3E-AFD3-9A53BA391302 Q26765157-C1DF51C8-92AA-445A-82CD-4C73182E1C72 Q27024621-C8D270CA-A57C-481B-A163-177FF47CD7EF Q28468724-CE6AFA87-CABE-4A11-A8E6-3651C73D2B1B Q28740395-DFA0DDBF-BC44-428E-B09F-3942AF73E953 Q30238911-1A976BA5-982F-460A-B7FE-6A5FBE7C2634 Q30239037-61D17481-54CC-4DC0-8BE4-7807A66DEC5A Q30514101-F3FBE63C-73B9-4807-9E25-2DFB814AE1AC Q33455764-DD02756C-2A5B-49D6-A736-FA0A89C4954B Q33883689-5296480E-6DCA-4904-8963-26932A59DCDD Q33949393-F501549D-41B3-4B52-A365-D41222497F2D Q34178297-66E5814B-3CD1-4169-8435-BEFCC5A05D80

P2860

First-line drugs for hypertension

http://www.wikidata.org/entity/Q24239935

description

2009 nî lūn-bûn

@nan

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

First-line drugs for hypertension

@ast

First-line drugs for hypertension

@en

First-line drugs for hypertension

@en-gb

First-line drugs for hypertension

@nl

type

label

First-line drugs for hypertension

@ast

First-line drugs for hypertension

@en

First-line drugs for hypertension

@en-gb

First-line drugs for hypertension

@nl

prefLabel

First-line drugs for hypertension

@ast

First-line drugs for hypertension

@en

First-line drugs for hypertension

@en-gb

First-line drugs for hypertension

@nl

P1433

Q24239935-A61A6679-34BB-4E1F-AFC8-04503BDDF334

P1476

Q24239935-D80B960E-6B48-4EFF-AFEB-3558D39F1D3B

P2093

Q24239935-1F30CC0C-3018-462F-907B-C238B2EA77AB

Q24239935-D4937C8D-22C0-47E7-AFF6-1946BEC55D73

P2860

Q24239935-082D38AB-FE5F-4EF2-AD05-F7496BB44FD7

Q24239935-0D55D0CC-F0D0-4FF5-A5FF-CE9C8C6D6EBF

Q24239935-28275767-0FEA-4449-AE36-1D8E6426A93A

Q24239935-30A3FAB9-C3CC-4A0E-9EE4-9BB5CAAD93FC

Q24239935-41853D02-E7DA-4B8D-B496-A37EA88B84F3

Q24239935-4C60941D-9667-40E9-B86E-8AB8632C4F31

Q24239935-A7B611FB-CDE5-482E-97C8-20996FA81A45

Q24239935-AA1C4257-B802-41B1-A837-DDEF289566DA

Q24239935-C157BE67-4FBB-4841-9B2E-729721FEB659

Q24239935-CAC1A37D-1DE0-49FD-9B5C-10DF8BD36D5E

P31

Q24239935-21722ac3-e757-468b-8a45-49ae9a6fc880

Q24239935-5CA12C8B-625E-40BC-894F-45D9F36D902C

P3181

Q24239935-135DD273-031A-454E-8FEB-F76CD883DCF5

P356

Q24239935-0D8FAB9B-54DA-43EC-B354-0DA9D64A07D7

P577

Q24239935-ACA751DA-5A3D-48D5-B0AB-CE8171DE6859

P698

Q24239935-3483543D-163B-4BDC-801A-B29BC9FDDFEC

P921

Q24239935-FFF329B2-58F8-4B9D-BE74-5CDCE326E8FD

P3181

P356

14651858.CD001841.PUB2

P1433

Cochrane Database of Systematic Reviews

P1476

First-line drugs for hypertension

@en

P2093

James M Wright

http://www.w3.org/2001/XMLSchema#string

Vijaya M Musini

http://www.w3.org/2001/XMLSchema#string

P2860

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

Long-term effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: The Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT).

Serum cholesterol levels and survival in elderly hypertensive patients: analysis of data from the European Working Party on High Blood Pressure in the Elderly.

Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: results of the HANE study. HANE Trial Research Group.

Department of veterans Affairs single-drug therapy of hypertension study. Revised figures and new data. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

The Hypertension in the Very Elderly Trial (HYVET). Rationale, methodology and comparison with previous trials.

Antihypertensive therapy in elderly patients. Pilot trial of the European Working Party on High Blood Pressure in the Elderly.

Renal function in the elderly: results from the European Working Party on High Blood Pressure in the Elderly trial.

Morbidity and mortality in the Systolic Hypertension in the Elderly Program (SHEP) pilot study.

P31

scholarly article

P3181

349700

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/14651858.CD001841.PUB2

http://www.w3.org/2001/XMLSchema#string

P577

2009-07-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19588327

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension